Mitotane — Drug Intelligence | 4 EU Trials

Filter these 4 trials by condition, phase, country and more.

4 Registered trials

3 Recruiting

0 Completed trials

12 Sponsors

4 Countries

Phase III

Phase II

Phase III: 1 Phase II: 3

Indications tested

4 total

PROSPECTIVE, PHASE II STUDY TO EVALUATE THE EFFICACY OF ADDITION OF PROGESTERONE TO STANDARD CHEMOTHERAPY ACCORDING TO EDP SCHEME PLUS MITOT… Pending

2024-520160-34-00 Phase II 1 country Azienda Socio Sanitaria Territoriale Degli Spedali Civili Di Brescia
Cemiplimab maintenance treatment for advanced adrenocortical cancer Recruiting

2024-520449-21-00 Phase II 1 country Azienda Socio Sanitaria Territoriale Degli Spedali Civili Di Brescia
Immunotherapy with dostarlimab for locally advanced or metastatic cancer (non-colorectal/non-endometrial) with tumor dMMR/MSI Recruiting

2023-505298-34-00 Phase II 1 country Unicancer
Adjuvant therapy in high risk adrenocortical carcinoma (ADIUVO-2) Recruiting

2022-500013-32-01 Phase III 3 countries Amsterdam UMC Stichting; Assistance Publique Hopitaux De Paris; Azienda Socio Sa…

Showing 1–4 of 4 trials